
Loading, please wait...

Loading, please wait...

The EPaNIC trial addressed a long-standing nutritional question: should parenteral nutrition be started early when enteral feeding is insufficient, or can it safely be delayed? More than 4,600 critically ill adults were randomised to early or late initiation of parenteral nutrition. Late initiation was associated with faster recovery from the ICU and hospital, fewer ICU infections, less cholestasis and shorter durations of mechanical ventilation and renal-replacement therapy. Mortality was not significantly different. The study challenged the assumption that rapidly closing a calorie deficit with parenteral nutrition necessarily improves outcomes. Instead, in patients who were not chronically malnourished and were receiving early enteral nutrition, the strategy of tolerating a period of nutritional deficit appeared beneficial. EPaNIC therefore influenced modern approaches to nutrition timing and highlighted the importance of distinguishing patients at high nutritional risk from those who can safely receive progressive enteral feeding. For clinicians, the practical message is not to withhold nutrition but to prioritise enteral feeding when feasible and avoid reflexive early parenteral supplementation simply to achieve a prescribed calorie target. Nutritional plans should consider baseline status, illness severity, gut function, metabolic tolerance and expected duration of critical illness. The trial remains central to discussions of nutrition and metabolism in the ICU.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The EPaNIC trial addressed a long-standing nutritional question: should parenteral nutrition be started early when enteral feeding is insufficient, or can it safely be delayed? More than 4,600 critically ill adults were randomised to early or late initiation of parenteral nutrition. Late initiation was associated with faster recovery from the ICU and hospital, fewer ICU infections, less cholestasis and shorter durations of mechanical ventilation and renal-replacement therapy. Mortality was not significantly different. The study challenged the assumption that rapidly closing a calorie deficit with parenteral nutrition necessarily improves outcomes. Instead, in patients who were not chronically malnourished and were receiving early enteral nutrition, the strategy of tolerating a period of nutritional deficit appeared beneficial. EPaNIC therefore influenced modern approaches to nutrition timing and highlighted the importance of distinguishing patients at high nutritional risk from those who can safely receive progressive enteral feeding. For clinicians, the practical message is not to withhold nutrition but to prioritise enteral feeding when feasible and avoid reflexive early parenteral supplementation simply to achieve a prescribed calorie target. Nutritional plans should consider baseline status, illness severity, gut function, metabolic tolerance and expected duration of critical illness. The trial remains central to discussions of nutrition and metabolism in the ICU.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back